Skip to main content
Caplight Logo









Full Cycle Bioplastics

Full Cycle Bioplastics

Private
San Jose, CaliforniaEnergy & Sustainabilityhttps://fullcyclebioplastics.com

Last Round

Bankruptcy

Jun 21, 2023

Total Funding Raised

$2.2M

Company Overview

Full Cycle Bioplastics is a clean technology company that develops a proprietary process to convert organic waste into polyhydroxyalkanoate (PHA), a compostable and marine-degradable bioplastic alternative to petroleum-based plastics.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotechnology, Circular Economy, Waste Management

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

polyhydroxyalkanoatesPHAbioplasticwaste-to-plasticcircular economybiodegradable polymerbiotechnologyfermentation technologymarine-degradable plasticsustainable packagingbioplastic resinwaste managementgreen chemistryplastic alternativeclimate tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Full Cycle Bioplastics Comparables

Compare Full Cycle Bioplastics with similar companies based on industry and business-model similarity.

Full Cycle Bioplastics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecis Bioindustries
88%
TerraVerdae Bioworks
86%
Mango Materials
83%

Full Cycle Bioplastics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
BankruptcyJun 21, 2023
Series AFeb 17, 2022
GrantJan 29, 2018
SeedApr 30, 2014

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2022

    Completed a Series A funding round.

Full Cycle Bioplastics Filings

Explore SEC and related filing metadata, where available.

Full Cycle Bioplastics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Full Cycle Bioplastics's valuation, stock price, and market status.

Is Full Cycle Bioplastics a public or private company?

Full Cycle Bioplastics is a private company.

What is the current stock price of Full Cycle Bioplastics?

Full Cycle Bioplastics is a private company with no public stock price. Caplight tracks Full Cycle Bioplastics's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Full Cycle Bioplastics worth (valuation)?

Valuation information for Full Cycle Bioplastics is not publicly available.

Can I buy Full Cycle Bioplastics stock?

Full Cycle Bioplastics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Full Cycle Bioplastics's last funding round?

Full Cycle Bioplastics's most recent funding round was Bankruptcy on June 21, 2023.

Who are the main investors in Full Cycle Bioplastics?

Investor information for Full Cycle Bioplastics is not publicly disclosed.

Will Full Cycle Bioplastics IPO soon?

No public IPO plans have been announced for Full Cycle Bioplastics.

How can I track Full Cycle Bioplastics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Full Cycle Bioplastics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Jose, California
Employee Range13
Year Founded2014
Last FundingJun 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?